Valthos

Valthos

AI-powered biosurveillance platform for biodefense

Overview

Valthos builds an AI-powered biosurveillance platform that aggregates data from air and wastewater monitoring, genomic sequencing, and public sources to detect emerging biological threats in real time. The system uses frontier AI to rapidly characterize biological sequences, identify anomalies, and speed up the design and deployment of medical countermeasures. Its leadership blends veterans from Palantir, Google DeepMind, Stanford’s Arc Institute, and MIT’s Broad Institute, combining data integration with life-sciences expertise to pursue proactive biodefense. The goal is to close the biodefense advantage by making threat detection and countermeasure development fast, data-driven, and adaptive through government contracts, public health programs, and defense licensing.

About Valthos

Simplify's Rating
Why Valthos is rated
C
Rated B on Competitive Edge
Rated C on Growth Potential
Rated D+ on Differentiation

Industries

Data & Analytics

Government & Public Sector

AI & Machine Learning

Biotechnology

Company Size

11-50

Company Stage

Seed

Total Funding

$30M

Headquarters

New York City, New York

Founded

2024

People at Valthos

People at Valthos who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Securing DoD IL5 authorization enables Valthos to handle CUI and NSS workloads for contracts.
  • Partnering with IL5-certified system integrators like Parallel Works eases deployment bottlenecks.
  • Azur eGovernment offers IL5 GPU compute that Valthos can adopt to capture biodefense demand.

What critics are saying

  • Valthos lacks DoD IL5 authorization, disqualifying it from core defense contracts within 6–12 months.
  • Zero federal procurement traction means high risk of failed pilot-to-contract conversion in 6–12 months.
  • DoD may mandate IL5 for all biodefense AI platforms by 2027, causing existential failure without revenue.

What makes Valthos unique

  • Valthos combines AI with biodefense to detect engineered biological threats in real time.
  • The firm leverages founders from Palantir, DeepMind, and Broad Institute for unique expertise.
  • It shifts biodefense from static response to dynamic, adaptive biological intelligence systems.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$30M

Above

Industry Average

Funded Over

1 Rounds

Notable Investors:
Seed funding is usually the first official round after pre-seed, when a startup has a prototype or concept. It’s typically used to develop the product, test the market, and start building the team. Investors here are often angel investors or early-stage venture capitalists.
Seed Funding Comparison
Above Average

Industry standards

$3.3M
$2M
Netflix
$2.3M
Instacart
$3M
Robinhood
$30M
Valthos

Growth & Insights

Headcount

6 month growth

-8%

1 year growth

-8%

2 year growth

-8%

Recently Posted Jobs

Sign up to get curated job recommendations

Valthos is Hiring for 7 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →